Nevirapine-associated hepatotoxicity in virologically suppressed patients--role of gender and CD4+ cell counts.
Mallolas
Josep
J
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000276:immunology; D008297:Male; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D012727:Sex Characteristics
D019380:Anti-HIV Agents; D019829:Nevirapine